SecSonar.com

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Zimmer Biomet Holdings, Inc. (ZBH) is a Medical - Devices company based in US with a market capitalization of $16B. Revenue grew 7.2% year-over-year and the company generated $1.5B in free cash flow. This page tracks ZBH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 17K employees · IPO Jul 25, 2001

Valuation

Valuation & price

$83.70 · as of May 17, 2026 · -22.3% vs 52w high

23.6

P/E ratio

Latest-FY diluted EPS

1.26

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$107$94.82$82.33Jul 25Dec 25Jul 26Jul 7, 25$92.57Jul 9, 25$95.20Jul 11, 25$93.79Jul 15, 25$94.03Jul 17, 25$94.90Jul 21, 25$92.59Jul 23, 25$97.33Jul 25, 25$97.55Jul 29, 25$94.95Jul 31, 25$91.65Aug 4, 25$92.40Aug 6, 25$91.15Aug 11, 25$100.02Aug 13, 25$103.22Aug 15, 25$102.75Aug 19, 25$104.31Aug 21, 25$104.42Aug 25, 25$107.32Aug 27, 25$106.79Aug 29, 25$106.10Sep 3, 25$105.04Sep 5, 25$105.73Sep 9, 25$103.85Sep 11, 25$104.26Sep 16, 25$99.12Sep 18, 25$100.21Sep 22, 25$101.74Sep 24, 25$98.98Sep 26, 25$98.24Sep 30, 25$98.50Oct 2, 25$99.17Oct 6, 25$98.83Oct 8, 25$98.36Oct 10, 25$94.71Oct 14, 25$98.37Oct 16, 25$99.92Oct 21, 25$102.69Oct 23, 25$103.16Oct 27, 25$103.12Oct 29, 25$99.71Oct 31, 25$100.56Nov 4, 25$103.18Nov 6, 25$88.51Nov 10, 25$88.73Nov 12, 25$90.03Nov 14, 25$89.91Nov 18, 25$89.08Nov 20, 25$89.07Nov 25, 25$97.07Nov 28, 25$97.52Dec 2, 25$94.14Dec 4, 25$93.16Dec 8, 25$92.75Dec 10, 25$93.09Dec 12, 25$91.59Dec 16, 25$90.91Dec 18, 25$90.40Dec 22, 25$89.80Dec 24, 25$90.23Dec 29, 25$90.53Jan 2, 26$90.02Jan 6, 26$94.75Jan 8, 26$94.08Jan 12, 26$91.45Jan 14, 26$89.24Jan 16, 26$87.31Jan 21, 26$86.55Jan 23, 26$86.60Jan 27, 26$85.99Jan 29, 26$86.02Feb 2, 26$86.22Feb 4, 26$88.09Feb 9, 26$89.73Feb 11, 26$95.61Feb 13, 26$96.45Feb 18, 26$98.25Feb 20, 26$98.75Feb 24, 26$99.87Feb 26, 26$100.99Mar 2, 26$99.49Mar 4, 26$95.75Mar 6, 26$94.11Mar 10, 26$91.70Mar 12, 26$92.63Mar 17, 26$92.52Mar 19, 26$89.84Mar 23, 26$87.80Mar 25, 26$87.64Mar 27, 26$88.57Mar 31, 26$90.42Apr 2, 26$90.89Apr 7, 26$91.40Apr 9, 26$93.03Apr 13, 26$95.34Apr 15, 26$94.20Apr 17, 26$94.78Apr 22, 26$93.04Apr 24, 26$91.26Apr 28, 26$82.80Apr 30, 26$82.43May 4, 26$82.67May 6, 26$82.83May 8, 26$82.33May 12, 26$83.37May 14, 26$82.65May 18, 26$85.14May 20, 26$85.38May 22, 26$85.50May 28, 26$82.82Jun 1, 26$82.94Jun 3, 26$84.98Jun 5, 26$87.33Jun 9, 26$89.63Jun 11, 26$87.14Jun 15, 26$88.26Jun 17, 26$87.16Jun 22, 26$87.09Jun 24, 26$90.56Jun 26, 26$93.10Jul 2, 26$87.47
$79.5852-week range$107.71
Loading valuation history…

Fundamentals

Key fundamentals

$16B

Market cap

7.2%

Revenue growth (YoY)

61.6%

Gross margin

$1.5B

Free cash flow (USD)

$6.9B

Net debt

-2.5%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$7.7BFY 2017$7.8BFY 2018$7.9BFY 2019$8.0BFY 2020$6.1BFY 2021$6.8BFY 2022$6.9BFY 2023$7.4BFY 2024$7.7BFY 2025$8.2B
$7.7B$8.2B

Free cash flow by year

2016 → 2025

FY 2016$1.4BFY 2017$1.4BFY 2018$1.6BFY 2019$1.2BFY 2020$1.1BFY 2021$1.3BFY 2022$1.1BFY 2023$1.2BFY 2024$1.1BFY 2025$1.5B
$1.4B$1.5B

Gross margin by year

2021 → 2025

FY 202171.3%FY 202270.9%FY 202371.8%FY 202471.5%FY 202561.6%
71.3%61.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCredit Agreement ExecutedJun 29, 2026Filing
  • 8-K eventAnnual Shareholder MeetingMay 27, 2026Filing
  • 8-K eventShare Repurchase IncreaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 1, 2026Filing
  • 8-K eventEarnings ReleaseApr 28, 2026Filing
  • 8-K eventCFO DepartureApr 28, 2026Filing

Questions

Frequently asked questions

What is Zimmer Biomet Holdings, Inc.'s market cap?

Zimmer Biomet Holdings, Inc. (ZBH) has a market capitalization of $16B.

What is ZBH's P/E ratio?

ZBH trades at a price-to-earnings ratio of 23.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ZBH's price-to-book (P/B) ratio?

ZBH trades at 1.26 times book value per share.

Are insiders buying ZBH stock?

SEC Form 4 filings show no open-market insider buys at Zimmer Biomet Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

SNN

Smith & Nephew plc

$12.7B

ALGN

Align Technology, Inc.

$12.6B

PEN

Penumbra, Inc.

$12.5B

STE

STERIS plc

$20.9B

GMED

Globus Medical, Inc.

$11.1B

PODD

Insulet Corporation

$9.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.